Icecure Medical Ltd Ord (ICCM) Stock Price, Quote & News

Company Profile

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 4 623 0333

Fax: 972 4 623 0222

Website: www.icecure-medical.com

Address:

7 Ha’Eshel Street, PO Box 3163, Caesarea, Israel

Darknight77 Aug. 4 at 9:35 PM

$ICCM Dreamers here.

1 · Reply

counter Aug. 4 at 7:48 PM

$ICCM I want to bring attention to $BMRA that i pinned out as a "5" count...a while ago...pay attention where it went to...a wolf wave calls for retracements of point 1 to 4...a similar look appears...fans 'seem' to line up

0 · Reply

Tom678 Aug. 4 at 7:46 PM

$ICCM patience is key here !! A lot of good news will come very soon

0 · Reply

counter Aug. 4 at 7:41 PM

$ICCM Im still playing with the count....hypothetically...if this is a 5...we target $3.10+...BUT...(dont get too excited)...another area points to about 9.50....our "problem" we suffer right now' is just waiting for FDA

0 · Reply

Darknight77 Aug. 4 at 7:19 PM

$ICCM Downtime in 21 minutes

0 · Reply

Tonyboner Aug. 4 at 5:56 PM

$ICCM They played this so well to get the offering done with that news, how many bought that day on the news, now regretting it. Level 2 looks real ugly .

0 · Reply

counter Aug. 4 at 5:50 PM

$ICCM i think what were seeing right now-the people that follow this...theyre rolling a big bet-short it all day long hoping those holding will sell try to buy back lower...problem with their thesis..the news could come at any time...as a result as we approach the close, they cover for their few measly pennies (you dont wanna get your head torn off by 4pm news)...just my opinion...EVERYTHING'S there..cash is 'ok'...enough to ride it out...im holding what i have...and if it REALLY dips...adding...remember-right now theyre trying to apply MAX PRESSURE to sell...."if" on FDA approval (really think about this...99% efficacy rate for their cure tests)...without looking at the price, what comes to mind right away???...look at simple words "CANCER CURE"...THEN THINK TO YOURSELF.."WAS I INSANE TO SELL TRY TO BUY BACK LOWER"????

1 · Reply

Tonyboner Aug. 4 at 5:47 PM

$ICCM This sees 80c before it sees a buck, big players are short and continue short.

0 · Reply

Tonyboner Aug. 4 at 5:46 PM

$ICCM ICCM Shareholders got played like a piano.

0 · Reply

Darknight77 Aug. 4 at 5:45 PM

$ICCM Flushed out. Poop

0 · Reply

IceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 Million

Jul 25, 2025, 9:00 AM EDT - 10 days ago

IceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation

Jul 24, 2025, 9:00 AM EDT - 11 days ago

IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period

Jul 10, 2025, 8:00 AM EDT - 25 days ago

IceCure Announces Commencement of Rights Offering

Jul 3, 2025, 8:30 AM EDT - 4 weeks ago

IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025

Jun 25, 2025, 9:23 AM EDT - 5 weeks ago

IceCure Announces Record Date for Rights Offering for Up to $10 Million

Jun 9, 2025, 8:30 AM EDT - 2 months ago

IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes

May 28, 2025, 4:26 PM EDT - 2 months ago

IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript

May 28, 2025, 8:30 AM EDT - 2 months ago

IceCure Medical Reports First Quarter 2025 Financial Results

May 21, 2025, 8:30 AM EDT - 2 months ago

IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025

May 6, 2025, 8:30 AM EDT - 3 months ago

IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation

Apr 30, 2025, 8:30 AM EDT - 3 months ago

IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer

Apr 28, 2025, 8:30 AM EDT - 3 months ago

IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium

Apr 22, 2025, 8:30 AM EDT - 3 months ago

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation

Mar 27, 2025, 1:45 PM EDT - 4 months ago

IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:30 AM EDT - 4 months ago

IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America

Mar 24, 2025, 8:30 AM EDT - 4 months ago

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate

Mar 21, 2025, 8:30 AM EDT - 4 months ago

IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025

Mar 20, 2025, 8:30 AM EDT - 4 months ago

IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer

Mar 18, 2025, 8:30 AM EDT - 4 months ago

IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference

Mar 17, 2025, 8:30 AM EDT - 5 months ago

IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology

Mar 10, 2025, 8:30 AM EDT - 5 months ago

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery

Feb 24, 2025, 8:30 AM EST - 5 months ago

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel

Feb 4, 2025, 8:30 AM EST - 6 months ago

IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

Jan 27, 2025, 8:30 AM EST - 6 months ago

IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China

Jan 13, 2025, 7:00 AM EST - 7 months ago

IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America

Jan 6, 2025, 8:30 AM EST - 7 months ago

IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule

Jan 3, 2025, 8:30 AM EST - 7 months ago

European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology

Dec 16, 2024, 8:30 AM EST - 8 months ago

Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting

Nov 26, 2024, 1:46 PM EST - 8 months ago

IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 8:30 AM EST - 8 months ago

IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® Cryoablation

Nov 25, 2024, 8:30 AM EST - 9 months ago

IceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent Office

Nov 20, 2024, 8:30 AM EST - 9 months ago

IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024

Nov 19, 2024, 8:30 AM EST - 9 months ago

IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of Health

Nov 8, 2024, 7:00 AM EST - 9 months ago

FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer

Oct 29, 2024, 8:30 AM EDT - 9 months ago

Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders

Oct 21, 2024, 8:30 AM EDT - 10 months ago

IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System

Oct 7, 2024, 8:15 AM EDT - 10 months ago

IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference

Sep 24, 2024, 8:15 AM EDT - 11 months ago

IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate

Sep 16, 2024, 8:00 AM EDT - 11 months ago

Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues

Sep 12, 2024, 8:00 AM EDT - 11 months ago

IceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024

Sep 4, 2024, 8:30 AM EDT - 11 months ago

IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences

Aug 28, 2024, 8:30 AM EDT - 1 year ago

USPTO Grants Notice of Allowance for Additional Patent on IceCure's Novel Cryogenic Pump Technology: Reinforces IceCure's Global IP Leadership in Cryoablation Technologies

Aug 20, 2024, 3:29 PM EDT - 1 year ago

IceCure Medical Ltd (ICCM) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 8:30 AM EDT - 1 year ago

IceCure Medical Reports 20% Growth in ProSense® System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global Markets

Aug 14, 2024, 8:30 AM EDT - 1 year ago

IceCure's ProSense® Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of Surgery

Aug 13, 2024, 8:30 AM EDT - 1 year ago

IceCure Medical to Report Second Quarter 2024 Financial & Operational Results on August 20, 2024

Aug 7, 2024, 8:30 AM EDT - 1 year ago

IceCure Announces Positive Data from the Largest Multi-Institutional Study of its Kind: "Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials"

Jul 22, 2024, 8:30 AM EDT - 1 year ago

99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society

Jul 19, 2024, 4:30 PM EDT - 1 year ago

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

Darknight77 Aug. 4 at 9:35 PM

$ICCM Dreamers here.

1 · Reply

counter Aug. 4 at 7:48 PM

0 · Reply

Tom678 Aug. 4 at 7:46 PM

$ICCM patience is key here !! A lot of good news will come very soon

0 · Reply

counter Aug. 4 at 7:41 PM

0 · Reply

Darknight77 Aug. 4 at 7:19 PM

$ICCM Downtime in 21 minutes

0 · Reply

Tonyboner Aug. 4 at 5:56 PM

$ICCM They played this so well to get the offering done with that news, how many bought that day on the news, now regretting it. Level 2 looks real ugly .

0 · Reply

counter Aug. 4 at 5:50 PM

1 · Reply

Tonyboner Aug. 4 at 5:47 PM

$ICCM This sees 80c before it sees a buck, big players are short and continue short.

0 · Reply

Tonyboner Aug. 4 at 5:46 PM

$ICCM ICCM Shareholders got played like a piano.

0 · Reply

Darknight77 Aug. 4 at 5:45 PM

$ICCM Flushed out. Poop

0 · Reply

Tom678 Aug. 4 at 4:48 PM

$ICCM amazing !!!!

0 · Reply

Rick2058 Aug. 4 at 4:29 PM

$ICCM AI assessment of rights offering. https://www.stocktitan.net/news/ICCM/ice-cure-announces-expiration-and-results-of-approximately-two-times-cf1rryxu2sio.html

1 · Reply

Darknight77 Aug. 4 at 4:20 PM

$ICCM No FDA anything soon

1 · Reply

Tom678 Aug. 4 at 3:38 PM

$ICCM the sec news in August 1 had some amazing bullish stuff . Loaded more

0 · Reply

Tonyboner Aug. 4 at 2:35 PM

$ICCM just under a million shares and the market has only been open for an hour, it's dead money till they get approved and that's IF they get approved, most bio running, but this is hitting new lows.

0 · Reply

Tonyboner Aug. 4 at 2:33 PM

$ICCM Dilution is here, there is only one winner and that is the house, I feel for anyone who bought that deal, I think many got sucked in with that PR, looks like everyone will be tripping over one another to get out at the price of the offering, I've followed this company for a while now and know how they work.

0 · Reply

Darknight77 Aug. 4 at 2:19 PM

$ICCM Lower lows. Where the bulls at. lol

0 · Reply

Vector75 Aug. 4 at 1:36 PM

$ICCM bear trap before FDA news. Buy the dip!

0 · Reply

Tom678 Aug. 4 at 1:24 PM

$ICCM bought the dip. Thank you 😊

1 · Reply

Darknight77 Aug. 3 at 10:32 PM

$ICCM How low we go this week?

1 · Reply

MrTicker Aug. 1 at 8:58 PM

$ICCM Form POS AM IceCure Medical Ltd. 10K WIZARD 3:50 PM ET 8/1/2025 http://archive.fast-edgar.com/20250801/AN2TB22CLZ229T8222ZD2ZY2CWHKZ2224276 Filed on: August 1, 2025

0 · Reply

Tom678 Aug. 1 at 11:43 AM

$ICCM very soon

0 · Reply

Market Cap	59.28M
Revenue (ttm)	3.29M
Net Income (ttm)	-15.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-465.65%
Debt to Equity Ratio	0.00

Volume	1,996,600
Avg Vol	1,186,456
Day's Range	N/A - N/A
Shares Out	58.70M
Stochastic %K	27%
Beta	0.32
Analysts	Strong Sell
Price Target	$2.98